ARCHIVES

FDA Didn’t Punish Duke for Failing To Seek Proper Regulatory Clearance for Three Trials

This article is from The Cancer Letter archive.

Vol. 38 No. 04 | January 27, 2012

Download PDF Visit The Full Archive

Related Articles

Advisors Approve $50 Million NCI Effort To Attack Cancer On a Molecular Level

July 2, 1999

DCCP Board Approves Concepts For Three New RFAs, Contract Recompetitions

June 4, 1982

FDA Plans Safety Reviews Of Newly Approved Drugs; Drug Safety Bills Introduced In Senate.

February 2, 2007

Dana-Farber And Merck To Collaborate On Therapeutics.

February 15, 2008

In the cancer centers: San Antonio Cancer Institute gets a new director, funding commitments.

March 12, 2004

Signet Cell A Rising Trend In Patients Under Age 40

November 25, 2011